F13.26
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F13.26 refers to a condition where a person becomes dependent on sedatives, hypnotics, or anxiolytics — drugs commonly prescribed for sleep, anxiety, or calming purposes. This dependence is complicated by a persistent amnestic disorder, meaning the individual experiences ongoing memory loss directly linked to the use of these medications. This condition highlights the importance of careful prescription practices and monitoring when using these types of drugs to prevent dependence and cognitive issues.
Causes & Symptoms
Clinical Causes: Prolonged or excessive use of sedatives, hypnotics, or anxiolytics Chronic self-medication without medical supervision Use of high doses or combining medications to enhance effects History of substance use disorder or mental health issues Genetic predisposition to drug dependence Psychological factors such as high stress levels or trauma
Key Symptoms: Memory gaps or difficulties recalling recent events (anterograde amnesia) Persistent forgetfulness or inability to remember certain details Cravings for sedative or anxiolytic medications Using the drugs beyond prescribed durations or dosages Withdrawal symptoms if the medication is reduced or stopped Persistent focus on obtaining or using the drug Cognitive impairment affecting daily functioning
Diagnostic & Treatment
Diagnosis Path: Diagnosing this condition involves a thorough medical history review, including medication use patterns, and a physical and neurological examination. Healthcare providers may employ cognitive assessments to evaluate memory issues. Laboratory tests, such as blood tests, can help rule out other conditions. Sometimes, imaging studies like MRI or CT scans are used to exclude structural brain problems. It is vital to assess whether the memory problems are directly attributable to medication use.
Treatment Protocols: Treatment strategies typically focus on reducing dependence and managing cognitive impairments. Approaches include: - Supervised medication tapering to safely reduce drug use - Behavioral therapies aimed at addressing underlying psychological factors - Cognitive rehabilitation programs to improve memory and cognitive functions - Support groups or counseling for addiction recovery - Monitoring and managing withdrawal symptoms While medication may sometimes be used for associated symptoms, ongoing supervision by healthcare professionals is crucial to avoid relapse and ensure safety.
Clinical Advice & FAQs
Billing Guidance
Is F13.26 a billable ICD-10 code?
Yes, F13.26 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.26?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
